We are a clinical-stage biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions. Our lead investigational product is the LOMECEL-B™ cell-based therapy product (“Lomecel-B”), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. We believe that by using the same cells that […]

We are a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we […]

We intend to focus our search on the traditional and non-traditional restaurant sectors in North America. Our management team has over 100 years of combined experience in North America as founders, owners, executives and advisors in the restaurant industry – in segments ranging from quick service to fine dining. Our chairman, Rafael Felipe de Jesús Aguirre […]

This is the second Israeli tech-focused blank-check company or SPAC sponsored by an affiliate of ION Asset Management of Israel. (Incorporated in the Cayman Islands) From the prospectus: We intend to focus on the rapidly growing universe of Israeli companies and entrepreneurs that apply technology and innovation to everyday lives.  Our sponsor is an affiliate […]

This is the second PropTech-focused blank-check company or SPAC sponsored by an affiliate of Tishman Speyer Properties, one of the world’s leading real estate owners, developers, operators and investment managers. Tishman Speyer had $56.8 billion in assets under management and 82.7 million square feet under management across 121 assets as of Sept. 30, 2020, the […]

(Note: This is Biophytis’ IPO of 1.2 million American Depositary Shares (ADS), with each ADS representing 10 ordinary shares. Technically this is an uplift or an “uplisting” of Biophytis stock to the NASDAQ, instead of a traditional IPO. The French biotech’s ordinary shares are listed on the Euronext Growth exchange in Paris under the symbol […]

This is the first blank-check company or SPAC established by Lazard, which was founded in 1848 in New Orleans. Lazard is one of the world’s leading financial advisory firms. As of Dec. 31, 2020, Lazard’s asset management business managed about $259 billion of assets on behalf of corporations, public funds, sovereign entities, endowments and foundations, labor […]

We intend to focus our search on technology-enabled businesses that offer specific technology solutions, broader technology software and services in the financial services sector.  (Note: ScION Tech Growth II priced its SPAC IPO on  Feb. 9, 2021, in line with the terms in its prospectus: 30 million units at $10 each to raise $300 million.)

We intend to initially focus our search on identifying a prospective target business in North America within the renewable and transition energy sector, with a focus on pursuing growth opportunities that are driving the electrical power grid transition, both on the electrical supply and on the demand side for high-intensity electrical users, as well as seeking […]

(Note:  This is a blank-check company backed by Energy Capital Partners ( ECP). Tyler Reeder, the president and CEO, is an ECP managing partner.) We intend to focus our search for a business combination target on, and use ECP’s and our directors’ and officers’ vast transactional experience and deep networks to pursue, businesses located in […]